- 中文名稱
心鈉肽前體Elisa試劑盒
- 英文名字
- NT-proANP ELISA Kit
- 供應商
- Biomedica Immunoassays
- 產品貨號
- BI-20892
- 產品報價
- ¥12x8tests

- 產品說明書
- 點擊查看
- 購買方式
- 90%產品中國有現貨庫存。銀行轉賬、電匯、支票、現金,在線支付寶及網銀支付,或直接與我們電話聯系400-6800-868
- 產品新聞

- 背景資料
- N-terminal proatrial natriuretic peptide (NT-proANP 1-98) is the biologically inactive fragment (98 amino acid) of the ANP prohormone.
ANP is translated from its gene as a 151-amino acid precursor, pre-proANP. After removal of the 25-amino acid signal peptide, the tissue form of the hormone, a 126-amino acid proANP (γ-ANP) is generated. γ-ANP is proteolytically cleaved to the biologically active ANP (α-ANP) and to the 98 amino acid NT-proANP peptide (also known as proANP 1-98). The major molecular forms of circulating human ANP is thus the 28 amino-acid peptide (α-ANP) that contains a ring structure with a disulfide bridge and the 98-amino acid NT-proANP peptide, which is easier to detect in the circulation due to its longer half-life. Both peptides α-ANP and NT-proANP circulate in equimolar amounts.
ANP is secreted from the heart in response to atrial stretching or through stimulation by angiotensin II and endothelin. The most important stimulus for the release of the hormone into circulation is stretching of myocyte fibres. On release, the prohormone is split into equimolar amounts of the highly biologically active proANP (99-126), also known as ?-ANP or ANP, and the N-terminal part proANP (1-98) (also known as NT-proANP) (Nakagawa et al., 2019; Volpe et al., 2015).
NT-proANP is more stable and has a longer half-life (60-120 min) in circulation than ANP which is rapidly cleared from the circulation with a half-life of 3-4 minutes (Yandle et al., 1986). The natriuretic peptides have a common characteristic biochemical structure that consists of a ring of 17 amino acids and a disulfide bridge between 2 cysteine molecules (Clerico et al., 2011; Volpe et al., 2015; Yandle et al., 1986).
The ANP prohormone undergoes several cleavages to generate the biologically active form of the hormone. N-terminal (NT) prohormone fragments of natriuretic peptides are typically more stable, have longer half-lives, and circulate at higher concentrations compared to C-terminal biologically active hormone ends (Yandle et al., 1986). It has therefore been suggested that measuring NT prohormone fragments of ANP provide more accurate concentrations in samples (Clerico et al., 2011).
The expression and secretion of ANP increase significantly in pathological states accompanied by stretching the heart chambers, volume overload, and ischemic injury, such as heart failure and myocardial infarction.
- 產品描述
- Method
Sandwich ELISA, HRP/TMB, 12×8-well detachable strips
Sample type
Serum, EDTA plasma, citrate plasma, hepar?n plasma, urine, cell culture supernatant (in human, rat, mouse samples)
Sample volume
10 μl / well
Assay time
3 h / 30 min
Sensitivity
0.05 nmol/l (= 0.64 ng/ml)
Standard range
0 – 10 nmol/l (= 0 – 127 ng/ml)
Conversion factor
1 nmol/l = 12.7 ng/ml (MW: 12.7 kDa)
Precision
In-between-run (n=3): ≤ 9 % CV
Within-run (n=5): ≤ 5 % CV
Specificity
Endogenous and recombinant human NT-proANP (equivalent to proANP 1-98)
Very high sequence homology between human and rodent (rat, mouse) NT-proANP (the assay is suitable for rat and mouse samples)
Cross-reactivity
proANP (1-30) <1%, proANP (31-67) <1%, proANP (79-98) <1%, alpha ANP (99-126)<1%
proBNP (8-29) <1%, proBNP (32-57) <1%
proCNP (1-19) <1%, proCNP (30-50) <1%, proCNP (51-97) <1%
- 產品特點
- 保存建議
- +4°C
- 其他
- Biomedica Immunoassay(bmgrp)公司成立于1988年, 總部位于奧地利維也納,主要致力于研究、開發和生產基于ELISA方法用于臨床前研究相關標記物檢測的工具。迄今為止Biomedica Immunoassay公司在心血管檢測及骨代謝檢測領域開發了一系列特色ELISA檢測試劑盒,Biomedica Immunoassay的生產過程符合GMP/GLP指南,并符合ISO 9001:2015管理體系,有CE認證。Biomedica Immunoassay的產品根據FDA, EMEA和ICH指南進行驗證,并具有驗證報告。
-

- 注意
-
該頁面的中文產品信息的翻譯,僅供參考。準確的產品信息請以廠家的英文說明書為準。下單前,請瀏覽說明書確認。
-